How can the enormous potential of artificial intelligence (AI) be harnessed to improve clinical outcomes across conditions such as cancer, cardiovascular and neurological disease, and mental health and substance use? That is the question at the center of the World Medical Innovation Forum, to be hosted by Partners HealthCare on April 8-10 at Boston’s Westin Copley Place.
The forum, titled “Where AI Meets Clinical Care,” will feature physicians and researchers from Brigham Health, Massachusetts General Hospital, Massachusetts Eye and Ear, Newton-Wellesley Hospital, and the Partners network, along with industry, finance and government leaders. Sessions will take a deep dive into the impact of AI on disease, as well as its potential implications across digital health, academic medicine and clinical trials, and value-based care, among others. The Forum will also feature provider AI strategies, 50 AI medical application use cases, and clinical and technology visionaries imagining medicine in 2054. Nearly 2000 attendees are convened to discuss and debate the future of healthcare.
CEOs and top executives of Bayer, Biogen, Bristol-Myers Squibb, GE Healthcare, Nuance, NVIDIA, Philips, Siemens Healthineers, Wolters Kluwer Health as well as Massachusetts Governor Charlie Baker, Secretary of Health and Human Services Alex Azar, Deepak Chopra, MD, former Secretary of Defense Ash Carter and CMS Administrator Seema Verma are among the many speakers.
Chaired by Partners Interim President and CEO Anne Klibanski, MD, and Gregg Meyer, MD, Chief Clinical Officer, the Forum was established five years ago to respond to the intensifying transformation of health care and its impact on innovation. Its goal is to help establish a shared commitment to improving patient lives with innovation across industry and academia. This year is the second consecutive Forum focused on the growing impact of AI across clinical applications.
According to Partners’ Chief Innovation Officer Chris Coburn, “The excitement around AI is fueled by the extraordinary promise it holds for all stakeholders in healthcare. Much remains to be realized, but these early innovations are remarkable, for their capacity to improve care and to shape the next wave of AI technologies in health care.”